Will cell reprogramming resolve the embryonic stem cell controversy? a narrative review

Annals of Internal Medicine

Volumn 155, Issue 2, 2011, Pages 114-121

  Power, Carl ^a   Rasko, John E J ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

KRUPPEL LIKE FACTOR 4; LENTIVIRUS VECTOR; MYC PROTEIN; RETROVIRUS VECTOR;

ALLOGRAFT; AUTOTRANSPLANTATION; BLOOD CELL; CELL CLONING; CELL DIFFERENTIATION; CELL NUCLEUS TRANSPLANTATION; CELL PROLIFERATION; CELL RENEWAL; CELL TRANSDIFFERENTIATION; EMBRYO DEVELOPMENT; EMBRYONIC STEM CELL; EPIGENETICS; FRAGILE X SYNDROME; FUNDING; GAMETOGENESIS; GENE INSERTION; GENE MUTATION; GENETIC COMPLEMENTATION; GOVERNMENT; GRAFT RECIPIENT; HAPLOIDY; HEART MUSCLE CELL; HEMANGIOBLAST; HEMATOPOIETIC CELL; HLA MATCHING; HUMAN; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; INNER CELL MASS; LAW; LENTIVIRINAE; MEDICAL ETHICS; MESENCHYMAL STEM CELL; MORALITY; MUTAGENESIS; NERVE CELL; NEURAL STEM CELL; NONHUMAN; NUCLEAR REPROGRAMMING; OLIGODENDROGLIA; PANCREAS ISLET BETA CELL; PLURIPOTENT STEM CELL; PRIMORDIAL GERM CELL; PRIORITY JOURNAL; PROGENY; REGENERATIVE MEDICINE; REPRODUCTION; RETINA CELL; RETINA MACULA DEGENERATION; RETROVIRUS; REVIEW; SKIN CELL; SOMATIC CELL; SPINAL CORD INJURY; STEM CELL RESEARCH; THORAX INJURY; TRANSGENE; TROPHOBLAST;

EID: 79960607693     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-155-2-201107190-00007     Document Type: Review

References (80)

1. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, et al. Embryonic stem cell lines derived from human blastocysts. Science. 1998;282:1145-7.
2. Menendez P, Bueno C, Wang L. Human embryonic stem cells: a journey beyond cell replacement therapies. Cytotherapy. 2006;8:530-41.
3. Jaenisch R. Nuclear cloning, embryonic stem cells, and gene transfer. In: Rasko JE, O'Sullivan G, Ankeny RA, eds. The Ethics of Inheritable Genetic Modification: A Dividing Line? Cambridge, UK: Cambridge Univ Pr; 2006:35-55.
4. Wilmut I, Schnieke AE, McWhir J, Kind AJ, Campbell KH. Viable offspring derived from fetal and adult mammalian cells. Nature. 1997;385:810-3.
5. French AJ, Adams CA, Anderson LS, Kitchen JR, Hughes MR, Wood SH. Development of human cloned blastocysts following somatic cell nuclear transfer with adult fibroblasts. Stem Cells. 2008;26:485-93.
6. Li J, Liu X, Wang H, Zhang S, Liu F, Wang X, et al. Human embryos derived by somatic cell nuclear transfer using an alternative enucleation approach. Cloning Stem Cells. 2009;11:39-50.
7. The Hinxton Group. World stem cell policies. Accessed at www.hinxtongroup.org/wp.html on 14 March 2011.
8. Robertson JA. Embryo stem cell research: ten years of controversy. J Law Med Ethics. 2010;38:191-203.
9. The White House; Bush GW. President discusses stem cell research [Press release]. 9 August 2001. Accessed at http://georgewbush-whitehouse.archives.gov/news/releases/2001/08/20010809-2.html on 14 March 2011.
10. The White House; Obama B. Remarks of President Barack Obama-as prepared for delivery: signing of stem cell executive order and scientific integrity presidential memorandum. 9 March 2009. Accessed at www.whitehouse.gov/the_press_office/Remarks-of-the-President-As-Prepared-for-Delivery-Signing-of-Stem-Cell-Executive-Order-and-Scientific-Integrity-Presidential-Memorandum/ on 14 March 2011.
11. Sherley et al. v. Sebelius et al, 704 F. Supp. 2d 63 (D. DC 2010).
12. Wadman M. Stem-cell work thrown into limbo. Nature. 2010;467:12-3.
13. Wadman M. US stem-cell funding ban overturned. Nature. 2011;473:15.
14. The President's Council on Bioethics. Alternative sources of human pluri-potent stem cells. White paper. Washington, DC: U.S. Department of Health and Human Services; 2005. Accessed at http://bioethics.georgetown.edu/pcbe/reports/white_paper/alternative_sources_white_paper.pdf on 14 March 2011.
15. Rao M, Condic ML. Alternative sources of pluripotent stem cells: scientific solutions to an ethical dilemma. Stem Cells Dev. 2008;17:1-10.
16. Kastenberg ZJ, Odorico JS. Alternative sources of pluripotency: science, ethics, and stem cells. Transplant Rev (Orlando). 2008;22:215-22.
17. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126:663-76.
18. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131:861-72.
19. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science. 2007;318:1917-20.
20. Park IH, Zhao R, West JA, Yabuuchi A, Huo H, Ince TA, et al. Repro-gramming of human somatic cells to pluripotency with defined factors. Nature. 2008;451:141-6.
21. The White House: Bush GW. Statement by the press secretary [Press release]. 20 Novemeber 2007. Accessed at http://georgewbush-whitehouse.archives.gov/news/releases/2007/11/20071120-5.html on 14 March 2011.
22. Hirami Y, Osakada F, Takahashi K, Okita K, Yamanaka S, Ikeda H, et al. Generation of retinal cells from mouse and human induced pluripotent stem cells. Neurosci Lett. 2009;458:126-31.
23. Karumbayaram S, Novitch BG, Patterson M, Umbach JA, Richter L, Lind-gren A, et al. Directed differentiation of human-induced pluripotent stem cells generates active motor neurons. Stem Cells. 2009;27:806-11.
24. Raya A, Rodríguez-Piza I, Guenechea G, Vassena R, Navarro S, Barrero MJ, et al. Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells. Nature. 2009;460:53-9.
25. Zhang J, Wilson GF, Soerens AG, Koonce CH, Yu J, Palecek SP, et al. Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ Res. 2009;104:e30-41.
26. Tateishi K, He J, Taranova O, Liang G, D'Alessio AC, Zhang Y. Generation of insulin-secreting islet-like clusters from human skin fibroblasts. J Biol Chem. 2008;283:31601-7.
27. Szabo E, Rampalli S, Risueño RM, Schnerch A, Mitchell R, Fiebig-Comyn A, et al. Direct conversion of human fibroblasts to multilineage blood progenitors. Nature. 2010;468:521-6.
28. Rasko JE. Transdifferentiation: an attractive concept in search of evidence [Editorial]. Pathology. 2003;35:5.
29. Law, science, and innovation. Proceedings of a symposium. May 2009. Austin, Texas, USA. J Law Med Ethics. 2010;38:175-440.
30. Narsinh KH, Sun N, Sanchez-Freire V, Lee AS, Almeida P, Hu S, et al. Single cell transcriptional profiling reveals heterogeneity of human induced plu-ripotent stem cells. J Clin Invest. 2011;121:1217-21.
31. Hu BY, Weick JP, Yu J, Ma LX, Zhang XQ, Thomson JA, et al. Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency. Proc Natl Acad Sci U S A. 2010;107:4335-40.
32. Feng Q, Lu SJ, Klimanskaya I, Gomes I, Kim D, Chung Y, et al. Heman-gioblastic derivatives from human induced pluripotent stem cells exhibit limited expansion and early senescence. Stem Cells. 2010;28:704-12.
33. Urbach A, Bar-Nur O, Daley GQ, Benvenisty N. Differential modeling of fragile X syndrome by human embryonic stem cells and induced pluripotent stem cells. Cell Stem Cell. 2010;6:407-11.
34. Eminli S, Foudi A, Stadtfeld M, Maherali N, Ahfeldt T, Mostoslavsky G, et al. Differentiation stage determines potential of hematopoietic cells for repro-gramming into induced pluripotent stem cells. Nat Genet. 2009;41:968-76.
35. Li H, Collado M, Villasante A, Strati K, Ortega S, Cañamero M, et al. The Ink4/Arf locus is a barrier for iPS cell reprogramming. Nature. 2009;460:1136-9.
36. Kim K, Doi A, Wen B, Ng K, Zhao R, Cahan P, et al. Epigenetic memory in induced pluripotent stem cells. Nature. 2010;467:285-90.
37. Polo JM, Liu S, Figueroa ME, Kulalert W, Eminli S, Tan KY, et al. Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells. Nat Biotechnol. 2010;28:848-55.
38. Hacein-Bey-Abina S, Von Kalle C, Schmidt M, McCormack MP, Wulf-fraat N, Leboulch P, et al. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science. 2003;302:415-9.
39. Yu J, Hu K, Smuga-Otto K, Tian S, Stewart R, Slukvin II, et al. Human induced pluripotent stem cells free of vector and transgene sequences. Science. 2009;324:797-801.
40. Hu K, Yu J, Suknuntha K, Tian S, Montgomery K, Choi KD, et al. Efficient generation of transgene-free induced pluripotent stem cells from normal and neoplastic bone marrow and cord blood mononuclear cells. Blood. 2011; 117:e109-19.
41. Zhou H, Wu S, Joo JY, Zhu S, Han DW, Lin T, et al. Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell. 2009; 4:381-4.
42. Kim D, Kim CH, Moon JI, Chung YG, Chang MY, Han BS, et al. Generation of human induced pluripotent stem cells by direct delivery of repro-gramming proteins. Cell Stem Cell. 2009;4:472-6.
43. Warren L, Manos PD, Ahfeldt T, Loh YH, Li H, Lau F, et al. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell. 2010;7:618-30.
44. Geron Corporation. Geron initiates clinical trial of human embryonic stem cell-based therapy [Press Release]. 11 October 2010. Accessed at www.geron.com/media/pressview.aspx?id=1235 on 14 March 2011.
45. Advanced Cell Technology. Advanced Cell Technology receives FDA clearance for clinical trials using embryonic stem cells to treat age-related macular degeneration [Press Release]. 3 January 2011. Accessed at www.advancedcell.com/news-and-media/press-releases/ on 3 June 2011.
46. Hyun I, Hochedlinger K, Jaenisch R, Yamanaka S. New advances in iPS cell research do not obviate the need for human embryonic stem cells [Letter]. Cell Stem Cell. 2007;1:367-8.
47. Thomson J. Keynote presentation: Reprogramming-a new vision for creating patient specific cells. Presented at World Stem Cell 2008 Summit, Madison, Wisconsin, 22-23 September 2008. Accessed at http://gpi.fullviewmedia.com/world-stem-cell-summit/html/03_Reprogramming-A-New-Vision-for-Creating-Patient-Specifc-Cells.html on 14 March 2011.
48. Holden C, Vogel G. Cell biology. A seismic shift for stem cell research. Science. 2008;319:560-3.
49. Laurent LC, Ulitsky I, Slavin I, Tran H, Schork A, Morey R, et al. Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture. Cell Stem Cell. 2011;8:106-18.
50. Pera MF. Stem cells: the dark side of induced pluripotency. Nature. 2011; 471:46-7.
51. Brown MT. Moral complicity in induced pluripotent stem cell research. Kennedy Inst Ethics J. 2009;19:1-22.
52. Hyun I. Stem cells from skin cells: the ethical questions. Hastings Cent Rep. 2008;38:20-2.
53. Sugarman J. Human stem cell ethics: beyond the embryo. Cell Stem Cell. 2008;2:529-33.
54. Aalto-Setala K, Conklin BR, Lo B. Obtaining consent for future research with induced pluripotent cells: opportunities and challenges. PLoS Biol. 2009;7: e42.
55. Zarzeczny A, Caulfield T. Emerging ethical, legal and social issues associated with stem cell research and the current role of the moral status of the embryo. Stem Cell Rev. 2009;5:96-101.
56. Sipp D. Gold standards in the diamond age: the commodification of pluripotency. Cell Stem Cell. 2009;5:360-3.
57. Cyranoski D. Stem cells: 5 things to know before jumping on the iPS bandwagon. Nature. 2008;452:406-8.
58. Clark AT, Bodnar MS, Fox M, Rodriquez RT, Abeyta MJ, Firpo MT, et al. Spontaneous differentiation of germ cells from human embryonic stem cells in vitro. Hum Mol Genet. 2004;13:727-39.
59. Ko K, Scholer HR. Embryonic stem cells as a potential source of gametes. Semin Reprod Med. 2006;24:322-9.
60. Park TS, Galic Z, Conway AE, Lindgren A, van Handel BJ, Magnusson M, et al. Derivation of primordial germ cells from human embryonic and induced pluripotent stem cells is significantly improved by coculture with human fetal gonadal cells. Stem Cells. 2009;27:783-95.
61. Kee K, Angeles VT, Flores M, Nguyen HN, Reijo Pera RA. Human DAZL, DAZ and BOULE genes modulate primordial germ-cell and haploid gamete formation. Nature. 2009;462:222-5.
62. Geijsen N, Horoschak M, Kim K, Gribnau J, Eggan K, Daley GQ. Derivation of embryonic germ cells and male gametes from embryonic stem cells. Nature. 2004;427:148-54.
63. Hübner K, Fuhrmann G, Christenson LK, Kehler J, Reinbold R, De La Fuente R, et al. Derivation of oocytes from mouse embryonic stem cells. Science. 2003;300:1251-6.
64. Nayernia K, Nolte J, Michelmann HW, Lee JH, Rathsack K, Drusen-heimer N, et al. In vitro-differentiated embryonic stem cells give rise to male gametes that can generate offspring mice. Dev Cell. 2006;11:125-32.
65. Mathews DJ, Donovan PJ, Harris J, Lovell-Badge R, Savulescu J, Faden R. Pluripotent stem cell-derived gametes: truth and (potential) consequences. Cell Stem Cell. 2009;5:11-4.
66. The Hinxton Group. Science, ethics and policy challenges of pluripotent stem cell-derived gametes. Rev Derecho Genoma Hum. 2008;29:219-22.
67. The National Archives. Human Fertilisation and Embryology Act 2008. Statute c. 22. Accessed at www.legislation.gov.uk/ukpga/2008/22/contents on 14 March 2011.
68. The Hinxton Group. United States: Current Legislation. Updated November 2009. Accessed at www.hinxtongroup.org/usa_map.html on 14 March 2011.
69. Mertes H, Pennings G. Ethical aspects of the use of stem cell derived gametes for reproduction. Health Care Anal. 2010;18:267-78.
70. Steinbock B. Designer babies: choosing our children's genes. Lancet. 2008; 372:1294-5.
71. Deng JM, Satoh K, Wang H, Chang H, Zhang Z, Stewart MD, et al. Generation of viable male and female mice from two fathers. Biol Reprod. 2011; 84:613-8.
72. Whittaker P. Stem cells to gametes: how far should we go? Hum Fertil (Camb). 2007;10:1-5.
73. Nagy A, Gócza E, Diaz EM, Prideaux VR, Iványi E, Markkula M, et al. Embryonic stem cells alone are able to support fetal development in the mouse. Development. 1990;110:815-21.
74. Kang L, Wang J, Zhang Y, Kou Z, Gao S. IPS cells can support full-term development of tetraploid blastocyst-complemented embryos. Cell Stem Cell. 2009;5:135-8.
75. Zhao XY, Li W, Lv Z, Liu L, Tong M, Hai T, et al. IPS cells produce viable mice through tetraploid complementation. Nature. 2009;461:86-90.
76. Mali P, Ye Z, Hommond HH, Yu X, Lin J, Chen G, et al. Improved efficiency and pace of generating induced pluripotent stem cells from human adult and fetal fibroblasts. Stem Cells. 2008;26:1998-2005.
77. Magill G, Neaves WB. Ontological and ethical implications of direct nuclear reprogramming. Kennedy Inst Ethics J. 2009;19:23-32.
78. Condic ML, Lee P, George RP. Ontological and ethical implications of direct nuclear reprogramming: response to Magill and Neaves. Kennedy Inst Ethics J. 2009;19:33-40.
79. Devolder K. To be, or not to be? Are induced pluripotent stem cells potential babies, and does it matter? EMBO Rep. 2009;10:1285-7.
80. Baertschi B, Mauron A. Moral status revisited: the challenge of reversed potency. Bioethics. 2010;24:96-103.